A Parade of Pharma Execs Have Been Asked About MFN This Week, and the Commentary Is (Unintentionally) Revealing
Shares:
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv
This is an important story from The Hill. Not because it’s insightful or even particularly good, but because I think it reflects a dangerous kind of conventional wisdom that is
The end of this week has Groundhog’s Day vibes to it. Yesterday, I wrote about falling net prices, which is something that I’ve been writing about for years even though